← All stocks

Viking Therapeutics, Inc.

VKTXPharmaceuticalsLatest filing used: 2026-10-29Filings on SEC EDGAR ↗

Fair value per share

No filings-based value

Too few comparable years of filings.

Last close

$29.23

Nov 13, 2026

How we decide

Ten years of results

Shares outstanding

Share count rose 46% over 9 years

FY2021: 77MFY2022: 77MFY2023: 94MFY2024: 109MFY2025: 113M075M150MFY16FY19FY22FY25112.7M
Show as table
YearShares outstanding
FY2016–
FY2017–
FY2018–
FY2019–
FY2020–
FY202177M
FY202277M
FY202394M
FY2024109M
FY2025113M

No revenue in the filings. No cash earnings in the filings. No dividends paid in these years.

Delayed quote

Delayed price and chart from TradingView. This site does not receive or store these prices, and the fair value above does not use them. Showing the chart sends TradingView this page's address, the widget type, the ticker and your IP address, and TradingView may collect analytics; see Privacy.

Open on Yahoo Finance ↗

Sources. Company figures: SEC EDGAR (XBRL filings), latest filing used 2026-10-29. Interest rate: U.S. Treasury, 10-year par yield, 2026-11-13. Last close: IEX Historical Data, 2026-11-13.